• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ON-X LIFE TECHNOLOGIES ONX AORTIC ANATOMIC EXT 21; HEART-VALVE, MECHANICAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ON-X LIFE TECHNOLOGIES ONX AORTIC ANATOMIC EXT 21; HEART-VALVE, MECHANICAL Back to Search Results
Model Number ONXANE-21
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem No Information (3190)
Event Date 08/21/2017
Event Type  Injury  
Manufacturer Narrative
This investigation is currently ongoing.Any additional information will be provided in the follow-up report.
 
Event Description
According to the implant recovery card (irc) received, (b)(6) male received onxane-21, sn (b)(4), on (b)(6) 2013 and required reintervention/explant on (b)(6) 2017 and subsequent replacement via onxa-19 due to undisclosed reason.Additional information is pending.
 
Manufacturer Narrative
Multiple requests to the surgeon for additional clarifying information were made without success to acquire the following information: patient¿s current status, indication for re-operation, available operative notes, patient impact, and pertinent patient co-morbidities.No response was received.The manufacturing records for the onxane-21, sn (b)(4), were reviewed and it was confirmed that all records were controlled, available for review, and met all specifications.All lots passed functional testing and met release specifications.During the investigation no non-conformances or deviations were noted.  onxane-21, sn (b)(4) implanted on (b)(6) 2013 in (b)(6) male; explanted on (b)(6) 2017 (3 years 295 days postop) and replaced by onxa-19, sn (b)(4) as reported to manufacturer's device tracking registration database.The explanted valve was not returned to the manufacturer and no other information was made available.The instructions for use (ifu) note the risk of explantation as a consequence of a complication, but we have no information on what complication may have prompted the procedure.Consequently, there is not enough information to know what, if any, relationship the explantation has to the valve.The ifu lists the following as potential adverse events: angina, cardiac arrhythmia, endocarditis, heart failure, hemolysis, hemolytic anemia, hemorrhage, myocardial infarction, prosthesis leaflet entrapment (impingement), prosthesis nonstructural dysfunction, prosthesis pannus, prosthesis perivalvular leak, prosthesis perivalvular leak, prosthesis regurgitation, prosthesis structural dysfunction, prosthesis thrombosis, stroke, and thromboembolism.It is possible that these complications could lead to reoperation and explantation.This event does not identify additional hazards or modify the probability and severity of existing hazards.
 
Event Description
According to the implant recovery card (irc) received, (b)(6) male received onxane-21, sn (b)(4), on (b)(6) 2013 and required reintervention/explant on (b)(6) 2017 and subsequent replacement via onxa-19 due to undisclosed reason.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ONX AORTIC ANATOMIC EXT 21
Type of Device
HEART-VALVE, MECHANICAL
Manufacturer (Section D)
ON-X LIFE TECHNOLOGIES
1300 e. anderson ln., bldg b
austin TX 78752
Manufacturer (Section G)
ON-X LIFE TECHNOLOGIES
1300 e. anderson ln., bldg. b
austin TX 78752
Manufacturer Contact
rochelle maney
1655 roberts blvd. nw
kennesaw, GA 30144
MDR Report Key6926358
MDR Text Key88997720
Report Number1649833-2017-00075
Device Sequence Number1
Product Code LWQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P000037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,user faci
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 12/11/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/07/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Model NumberONXANE-21
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Distributor Facility Aware Date09/11/2017
Date Manufacturer Received09/11/2017
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Other; Required Intervention;
Patient Age40 YR
-
-